While it is widely assumed that, in MS, complement proteins derived from the circulation enter the brain parenchyma through a leaky BBB to tag antigen-antibody complexes (“outside-in” paradigm), a potential role of CNS-derived complement components in MS disease processes that originate within the CNS (“inside-out” paradigm) has been largely ignored. This evidence concerns the gene VTN and myeloid sarcoma.